All Phenotypes Smarcb1<tm1Sho> MGI Mouse

About Help FAQ

Phenotypes associated with this allele

Allele Symbol
Allele Name
Allele ID

Smarcb1^tm1Sho
targeted mutation 1, Stuart Orkin
MGI:1931875

Summary

7 genotypes

Jump to	Allelic Composition	Genetic Background	Genotype ID
hm1	Smarcb1^tm1Sho/Smarcb1^tm1Sho	involves: 129S6/SvEvTac * C57BL/6	MGI:3035828
ht2	Smarcb1^tm1Sho/Smarcb1⁺	involves: 129S6/SvEvTac * C57BL/6	MGI:3035829
ht3	Smarcb1^tm1Sho/Smarcb1⁺	involves: 129S6/SvEvTac * C57BL/6J * DBA/2J	MGI:5538531
cn4	Smarcb1^tm1Sho/Smarcb1^tm2Sho Tg(Mx1-cre)1Cgn/?	involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA	MGI:3819384
cn5	Smarcb1^tm1Sho/Smarcb1^tm3Sho Tg(Mx1-cre)1Cgn/?	involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA	MGI:3819385
cn6	Smarcb1^tm1Sho/Smarcb1^tm3Sho Tg(Gata1-cre)1Sho/?	involves: 129S1/Sv * 129S6/SvEvTac * CD-1	MGI:3819386
cx7	Smarcb1^tm1Sho/Smarcb1⁺ Tg(LPV-TAg121)2Tvd/0	involves: 129S6/SvEvTac * C57BL/6J * DBA/2J	MGI:5538529

Allelic Composition	Smarcb1^tm1Sho/Smarcb1^tm1Sho
Genetic Background	involves: 129S6/SvEvTac * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Smarcb1^tm1Sho mutation (0 available); any Smarcb1 mutation (22 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

embryonic lethality between implantation and somite formation, complete penetrance ( J:66417 )

• embryos die prior to E7.5

Allelic Composition	Smarcb1^tm1Sho/Smarcb1⁺
Genetic Background	involves: 129S6/SvEvTac * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Smarcb1^tm1Sho mutation (0 available); any Smarcb1 mutation (22 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased tumor incidence ( J:66417 )

• 8 of 125 heterozygous mice developed aggressive tumors; primarily these are located in tissues derived from the first branchial arch (head and neck); the majority of these tumors were of a rhabdoid type

Allelic Composition	Smarcb1^tm1Sho/Smarcb1⁺
Genetic Background	involves: 129S6/SvEvTac * C57BL/6J * DBA/2J

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Smarcb1^tm1Sho mutation (0 available); any Smarcb1 mutation (22 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

decreased tumor-free survival time ( J:120820 )

• 24% of mutants become terminal with malignant rhabdoid tumors within 8 to 10 months of age at a median age of 8.2 months

neoplasm

increased malignant tumor incidence ( J:120820 )

• mice develop malignant rhabdoid tumors, with a median latency of 8 and 10 months of age for spinal cord and soft tissue tumors, respectively

• malignant rhabdoid tumors present as soft tissue tumors mostly on the face and limbs (20%) with occasional paravertebral sites close to the distal end of spinal cord (4%)

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
atypical teratoid rhabdoid tumor		DOID:2129	OMIM:609322	J:120820

Allelic Composition	Smarcb1^tm1Sho/Smarcb1^tm2Sho Tg(Mx1-cre)1Cgn/?
Genetic Background	involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Smarcb1^tm1Sho mutation (0 available); any Smarcb1 mutation (22 available)
Smarcb1^tm2Sho mutation (0 available); any Smarcb1 mutation (22 available)
Tg(Mx1-cre)1Cgn mutation (7 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:80224 )

• 90% mortality between 1 and 3 weeks after injection with polyI/polyC

• remaining mice die over the next 4 weeks

hematopoietic system

abnormal bone marrow cell morphology/development ( J:80224 )

• deficiency of hematopoietic cells in the bone marrow

pancytopenia ( J:80224 )

• mice are ill and profoundly pancytopenic by weeks 1-2 after polyI/polyC injection

• some mice develop mild or transient pancytopenia but still experience sudden death

cardiovascular system

bruising ( J:80224 )

• extensive skin bruising

intestinal hemorrhage ( J:80224 )

digestive/alimentary system

intestinal hemorrhage ( J:80224 )

Allelic Composition	Smarcb1^tm1Sho/Smarcb1^tm3Sho Tg(Mx1-cre)1Cgn/?
Genetic Background	involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Smarcb1^tm1Sho mutation (0 available); any Smarcb1 mutation (22 available)
Smarcb1^tm3Sho mutation (1 available); any Smarcb1 mutation (22 available)
Tg(Mx1-cre)1Cgn mutation (7 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased tumor incidence ( J:80224 )

• mice normal for about 4 weeks after polyI/polyC injection

• begin to develop cancers after 4 weeks

• 100% develop tumors with a median onset of 11 weeks after polyI/polyC injection

• sometimes an increase in circulating tumor cells

increased rhabdomyoma incidence ( J:80224 )

• 3 out of 23 mice with rhabdoid tumors

increased lymphoma incidence ( J:80224 )

• periportal lymphoma in the liver

increased T cell derived lymphoma incidence ( J:80224 )

• 20 of 23 mice have CD8+ T cell lymphomas

• tumor cell types suggestive of malignant lymphocytes

immune system

increased eosinophil cell number ( J:80224 )

• increase in circulating eosinophiles

abnormal spleen morphology ( J:80224 )

• effacement of normal architecture

enlarged spleen ( J:80224 )

• sometimes dramatically

abnormal lymph node morphology ( J:80224 )

• effacement of the normal architecture of involved lymph nodes

enlarged lymph nodes ( J:80224 )

hematopoietic system

abnormal blood cell morphology/development ( J:80224 )

• often a mild and progressive decrease in blood cell counts

increased eosinophil cell number ( J:80224 )

• increase in circulating eosinophiles

abnormal spleen morphology ( J:80224 )

• effacement of normal architecture

enlarged spleen ( J:80224 )

• sometimes dramatically

liver/biliary system

abnormal liver morphology ( J:80224 )

• periportal lymphomas

enlarged liver ( J:80224 )

• sometimes dramatically

cellular

increased apoptosis ( J:80224 )

• in liver and spleen 18-24 hours after polyI/polyC injection

endocrine/exocrine glands

increased T cell derived lymphoma incidence ( J:80224 )

• 20 of 23 mice have CD8+ T cell lymphomas

• tumor cell types suggestive of malignant lymphocytes

growth/size/body

enlarged liver ( J:80224 )

• sometimes dramatically

enlarged spleen ( J:80224 )

• sometimes dramatically

muscle

increased rhabdomyoma incidence ( J:80224 )

• 3 out of 23 mice with rhabdoid tumors

Allelic Composition	Smarcb1^tm1Sho/Smarcb1^tm3Sho Tg(Gata1-cre)1Sho/?
Genetic Background	involves: 129S1/Sv * 129S6/SvEvTac * CD-1

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

embryonic lethality ( J:80224 )

Allelic Composition	Smarcb1^tm1Sho/Smarcb1⁺ Tg(LPV-TAg121)2Tvd/0
Genetic Background	involves: 129S6/SvEvTac * C57BL/6J * DBA/2J

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Smarcb1^tm1Sho mutation (0 available); any Smarcb1 mutation (22 available)
Tg(LPV-TAg121)2Tvd mutation (1 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased malignant tumor incidence ( J:120820 )

• malignant rhabdoid tumors develop with increased frequency (55%) and reduced latency (median, 4.9 months) compared to single Smarcb1 heterozygotes

• both soft tissue and CNS tumor frequencies increase (32% and 24%, respectively)

• 44% of malignant rhabdoid tumors are located around the roots or spinal nerves within the spinal cord, most frequently near the thoracolumbar junction with a median age of 5.2 months

• malignant rhabdoid tumors have a more than a 4-fold increase in mitotic index compared with single Smarcb1 heterozygotes

increased carcinoma incidence ( J:120820 )

• 100% penetrance of choroid plexus carcinomas, with a median latency of 9 months, similar to single Tg(LPV-TAg121)2Tvd mice

Mouse Models of Human Disease	DO ID	OMIM ID(s)	Ref(s)
atypical teratoid rhabdoid tumor	DOID:2129	OMIM:609322	J:120820
choroid plexus papilloma	DOID:2626	OMIM:260500	J:120820

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/16/2024 MGI 6.23